LUNA Trial - Pasireotide LAR and/or Everolimus in Lung NETs

• Research type

  Research Study

• Full title

  Multicenter 3-arm trial to evaluate the efficacy and safety of Pasireotide LAR or Everolimus alone or in combination in patients with well differentiated neuroendocrine carcinoma of the lung and thymus -LUNA Trial

• IRAS ID

  120600

• Contact name

  Tim Meyer

• Contact email

  t.meyer@ucl.ac.uk

• Sponsor organisation

  Novartis Pharma Services AG

• Eudract number

  2011-002872-17

• ISRCTN Number

  n.a

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  13/LO/0473

• Date of REC Opinion

  24 Jun 2013

• REC opinion

  Further Information Favourable Opinion